Why the study?
Transgene packaging in AAV gene therapy vectors is usually imperfect, creating a need for a rapid and accurate method to measure the proportion of DNA encapsidation.
Answers are grounded in this paper and cite their sources.
Cryo-EM provides a rapid and accurate method for measuring the proportion of DNA encapsidation in AAV vectors, which is important for improving large-scale vector production.
Adeno-associated viruses (AAVs) have been employed successfully as gene therapy vectors in treating various genetic diseases for almost two decades. However, transgene packaging is usually imperfect, and developing a rapid and accurate method for measuring the proportion of DNA encapsidation is an important step for improving the downstream process of large scale vector production. In this study, we used two-dimensional class averages and three-dimensional classes, intermediate outputs in the single particle cryo-electron microscopy (cryo-EM) image reconstruction pipeline, to determine the proportion of DNA-packaged and empty capsid populations. Two different preparations of AAV3 were analyzed to estimate the minimum number of particles required to be sampled by cryo-EM in order for robust calculation of the proportion of the full versus empty capsids in any given sample. Cost analysis applied to the minimum amount of data required for a valid ratio suggests that cryo-EM is an effective approach to analyze vector preparations.
No takes yet. Share an insight, caveat, or question.
Subramanian et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: